In the last 12 months, insiders at Avalyn Pharma Inc. ($AVLN) filed 44 transactions with the SEC: 4 open-market purchases totaling $24,999,984 and 0 sales totaling $0. Net insider sentiment: net buying.
Avalyn Pharma Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- SR ONE CAPITAL MANAGEMENT, LLC (Not found) — 10 transactions totaling $9,999,990
- Novo Holdings A/S (Not found) — 7 transactions totaling $9,999,990
- Carroll Jill (Not found) — 5 transactions totaling $5,000,004
- Baranowski Lyn (Chief Executive Officer) — 1 transaction totaling $0
- Lazarus Howard (Chief Medical Officer) — 1 transaction totaling $0
View all SEC Filings for Avalyn Pharma Inc. (AVLN).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | Novo Holdings A/S | Not found | C | Series D Preferred Stock | 12558081 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2026 | FMR LLC | Not found | C | Common Stock | 727585 | $0.00 | 727,585.0000 | 0 | 9999.99% | 0.00% |
| May 1, 2026 | FMR LLC | Not found | C | Common Stock | 80291 | $0.00 | 807,876.0000 | 0 | 11.04% | 0.00% |
| May 1, 2026 | FMR LLC | Not found | C | Common Stock | 872868 | $0.00 | 1,680,744.0000 | 0 | 108.04% | 0.00% |
| May 1, 2026 | FMR LLC | Not found | C | Common Stock | 225843 | $0.00 | 1,906,587.0000 | 0 | 13.44% | 0.00% |
| May 1, 2026 | FMR LLC | Not found | C | Common Stock | 377948 | $0.00 | 2,284,535.0000 | 0 | 19.82% | 0.00% |
| May 1, 2026 | FMR LLC | Not found | C | Series A Preferred Stock | 727585 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2026 | FMR LLC | Not found | C | Series B Preferred Stock | 80291 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2026 | FMR LLC | Not found | C | Series C-1 Preferred Stock | 872868 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2026 | FMR LLC | Not found | C | Series C-2 Preferred Stock | 225843 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2026 | FMR LLC | Not found | C | Series D Preferred Stock | 377948 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2026 | Novo Holdings A/S | Not found | C | Voting Common Stock | 3327734 | $0.00 | 3,327,734.0000 | 0 | 9999.99% | 0.00% |
| May 1, 2026 | Novo Holdings A/S | Not found | P | Voting Common Stock | 555555 | $18.00 | 3,883,289.0000 | 0 | 16.69% | 0.00% |
| May 1, 2026 | Novo Holdings A/S | Not found | C | Series A Preferred Stock | 18000000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2026 | Novo Holdings A/S | Not found | C | Series B Preferred Stock | 1986369 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2026 | Novo Holdings A/S | Not found | C | Series C-1 Preferred Stock | 25899284 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2026 | Novo Holdings A/S | Not found | C | Series C-2 Preferred Stock | 5587603 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 29, 2026 | Golden Adam H. | General Counsel | A | Stock Option (Right to Buy) | 254891 | $0.00 | 254,891.0000 | 0 | 9999.99% | 0.00% |
| April 30, 2026 | Carlson Douglas R | Chief Financial Officer | A | Stock Option (Right to Buy) | 211975 | $0.00 | 211,975.0000 | 0 | 9999.99% | 0.00% |
| April 29, 2026 | Haviland Kate | Not found | A | Stock Option (Right to Buy) | 26978 | $0.00 | 26,978.0000 | 0 | 9999.99% | 0.00% |
| May 1, 2026 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | Not found | C | Common Stock | 1275486 | $0.00 | 1,275,486.0000 | 0 | 9999.99% | 0.00% |
| May 1, 2026 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | Not found | C | Series C-1 Convertible Preferred Stock | 20482289 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2026 | Carroll Jill | Not found | C | Common Stock | 1419298 | $0.00 | 1,419,298.0000 | 0 | 9999.99% | 0.00% |
| April 29, 2026 | Lazarus Howard | Chief Medical Officer | A | Stock Option (Right to Buy) | 211975 | $0.00 | 211,975.0000 | 0 | 9999.99% | 0.00% |
| April 30, 2026 | Lavelle Erin | Not found | A | Stock Option (Right to Buy) | 26978 | $0.00 | 26,978.0000 | 0 | 9999.99% | 0.00% |
| April 29, 2026 | Baranowski Lyn | Chief Executive Officer | A | Stock Option (Right to Buy) | 501033 | $0.00 | 501,033.0000 | 0 | 9999.99% | 0.00% |
| May 1, 2026 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | Not found | C | Series D Convertible Preferred Stock | 4060259 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2026 | Carroll Jill | Not found | C | Common Stock | 489486 | $0.00 | 1,908,784.0000 | 0 | 34.49% | 0.00% |
| May 1, 2026 | Carroll Jill | Not found | P | Common Stock | 277778 | $18.00 | 2,186,562.0000 | 0 | 14.55% | 0.00% |
| May 1, 2026 | Carroll Jill | Not found | C | Series C-1 Convertible Preferred Stock | 27309719 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2026 | Carroll Jill | Not found | C | Series D Convertible Preferred Stock | 9418561 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 1419298 | $0.00 | 2,541,385.0000 | 0 | 126.49% | 0.00% |
| May 1, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 489486 | $0.00 | 3,030,871.0000 | 0 | 19.26% | 0.00% |
| May 1, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | Not found | P | Common Stock | 277778 | $18.00 | 3,308,649.0000 | 0 | 9.16% | 0.00% |
| May 1, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 354824 | $0.00 | 2,541,386.0000 | 0 | 16.23% | 0.00% |
| May 1, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 489486 | $0.00 | 3,030,872.0000 | 0 | 19.26% | 0.00% |
| May 1, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | Not found | P | Common Stock | 277777 | $18.00 | 3,308,649.0000 | 0 | 9.16% | 0.00% |
| May 1, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series C-1 Convertible Preferred Stock | 27309719 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series D Convertible Preferred Stock | 9418561 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series C-1 Convertible Preferred Stock | 6827429 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series D Convertible Preferred Stock | 9418560 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 29, 2026 | Congleton Jon | Not found | A | Stock Option (Right to Buy) | 26978 | $0.00 | 26,978.0000 | 0 | 9999.99% | 0.00% |
| April 29, 2026 | Turner Heather D | Not found | A | Stock Option (Right to Buy) | 26978 | $0.00 | 26,978.0000 | 0 | 9999.99% | 0.00% |
| April 29, 2026 | Rhodes Melissa | Chief Operating Officer | A | Stock Option (Right to Buy) | 211975 | $0.00 | 211,975.0000 | 0 | 9999.99% | 0.00% |